Fundz

Takis S.r.l. partners with Sapienza University and Tethis to enhance HER3-targeted therapies for lung cancer.

Oct 03, 2025

Contract Type

partnership

RomeBiotechnologyHealth CareTherapeuticsBiopharmaresearch

Description

A new partnership has been formed between Takis S.r.l., the Department of Clinical and Molecular Medicine of Sapienza University of Rome, and Tethis to accelerate research on HER3-targeted therapies. The collaboration aims to develop innovative treatments and companion diagnostics for lung cancer patients as part of the HERCART project.

Company Information

Company

Takis S.r.l

Location

84 Via di Castel Romano

Rome, Lazio, Italy

About

Takis S.r.l. is a biopharmaceutical company focused on developing innovative therapies and diagnostics for cancer treatment. They specialize in antibody-based therapies and have a strong commitment to advancing cancer research. Their groundbreaking projects aim to improve patient outcomes through targeted approaches.

Predictive Intelligence
Strategic

ML-powered predictions for Takis S.r.l's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Takis S.r.l signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.